Department of Thoracic Surgery, University Hospital Arnaud de Villeneuve, Montpellier, France.
Eur J Cardiothorac Surg. 2012 Sep;42(3):444-53. doi: 10.1093/ejcts/ezs028. Epub 2012 Mar 4.
The reconstruction of large full thickness chest wall defect after resection of T3/T4 non-small cell lung cancer (NSCLC) or primary chest wall tumours presents a technical challenge for thoracic surgeons and is a critical factor in determining post-operative outcome. When the defect is large, complications are common with a 27% mean rate of respiratory morbidity.
Since 2006, 31 patients underwent reconstruction for wide chest wall defects using titanium implants and strong mesh. The reconstruction was achieved using a layer of polytetrafluoroethylene or a XCM biologic tissue mesh shaped to match the defect and sutured under maximum tension to re-establish the skeletal continuity. The mesh was placed close to the lung and was fixed onto the bony framework and onto the titanium plate. In one case, we used XCM biologic tissue because of a large infected T3 NSCLC. A horizontal titanium rib osteosynthesis system was used to reestablish the rigidity of the thoracic wall by bridging the defect except for one case in which we use a vertical rib osteosynthesis system.
Twenty-six patients underwent a complete R0 resection with the removal of a mean of 4.67 ± 1.5 [3-9] ribs, including the sternum in 14 cases. The mean defect area was 198 ± 91.2 [95-400] cm². Reconstruction required a mean of 2.06 ± 1.1 [1-4] titanium plates. There were two cases of deep wound infection that required surgical removal of the osteosynthesis system in one patient. Only one patient developed a major complication in the form of respiratory failure. There were two postoperative deaths neither of which was directly related to the surgical procedure.
Our experience and initial results show that titanium rib osteosynthesis in combination with strong biologic or synthetic mesh can easily and safely be used in a one-stage procedure for the reconstruction of major chest wall defects.
T3/T4 非小细胞肺癌(NSCLC)或原发性胸壁肿瘤切除后大面积全层胸壁缺损的重建对胸外科医生来说是一个技术挑战,也是决定术后结果的关键因素。当缺损较大时,并发症很常见,呼吸发病率平均为 27%。
自 2006 年以来,31 例患者因广泛胸壁缺损接受钛植入物和强网片重建。使用聚四氟乙烯或 XCM 生物组织网片进行重建,该网片形状与缺损匹配,并在最大张力下缝合,以重新建立骨骼连续性。将网片放置在靠近肺部的位置,并固定在骨框架和钛板上。在 1 例 T3 感染性 NSCLC 较大的情况下,我们使用 XCM 生物组织。使用水平钛肋骨骨合成系统通过桥接缺损来重建胸壁的刚性,除 1 例外均使用垂直肋骨骨合成系统。
26 例患者行 R0 完全切除,平均切除 4.67±1.5[3-9]根肋骨,包括 14 例胸骨。平均缺损面积为 198±91.2[95-400]cm²。重建需要平均 2.06±1.1[1-4]块钛板。有 2 例深部伤口感染,1 例患者需要手术取出骨合成系统。仅 1 例患者发生呼吸衰竭等严重并发症。术后死亡 2 例,均与手术无关。
我们的经验和初步结果表明,钛肋骨骨合成术结合强生物或合成网片可在一期手术中轻松、安全地用于重建大面积胸壁缺损。